Literature DB >> 7030898

Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes.

R S Gray, D Q Borsey, A Kurtz, S Rainbow, A F Smith, R A Elton, L J Duncan, B F Clarke.   

Abstract

Diabetic control, assessed by measuring the concentration in venous blood of total glycosylated haemoglobin (HbA1), endogenous insulin secretion, as estimated by the C-peptide response (delta C-P) to intravenous glucagon, and serum beef insulin antibody binding were measured in 50 juvenile onset insulin dependent diabetics (IDDM) receiving a single daily injection of soluble and protamine zinc insulin. The delta C-P correlated inversely with duration of diabetes (tau = -0.27, p less than 0.01) and daily insulin requirement (tau = -0.22, p less than 0.05) in the 50 IDDM studied of whom 28 exhibited a measurable delta C-P. In C-peptide nonresponders, but not in the C-peptide responders, and inverse regression (t = 2.19, p less than 0.05) was observed between beef insulin antibody and HbA1. In the 25 IDDM having the lowest insulin antibody binding, and inverse correlation (tau = 0.36, p less than 0.02) was observed between delta CP and HbA1, which was not found (tau = 0.05) in the remaining 25 IDDM who had the highest insulin antibody binding. These findings suggest that, in the absence of endogenous insulin secretion, diabetic control in IDDM receiving a single daily injection of conventional beef insulin is better in patients with high beef insulin antibody binding. Conversely, in patients with low beef insulin antibody binding, diabetic control appears to be better in those with persisting endogenous insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030898     DOI: 10.1055/s-2007-1019349

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.

Authors:  R S Gray; P Cowan; U di Mario; R A Elton; B F Clarke; L J Duncan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

2.  The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.

Authors:  N J Vaughan; J A Matthews; A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

3.  Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.

Authors:  E Bonora; C Coscelli; U Butturini
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

4.  Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 type 2 (non-insulin-dependent) diabetic patients.

Authors:  C Ionescu-Tîrgovişte; I Mincu; L Simionescu; D Cheţa; Z Mirodon; E Sântu; E Popa; A Bîrnea
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.